Browsing by Author Gazi, I. F.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 20 of 24  next >
TitleAuthor(s)Issue date
Acute infection with Epstein-Barr virus is associated with atherogenic lipid changesApostolou, F.; Gazi, I. F.; Lagos, K.; Tellis, C. C.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M.24-Nov-2015
Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic SyndromeLagos, K. G.; Filippatos, T. D.; Tsimihodimos, V.; Gazi, I. F.; Rizos, C.; Tselepis, A. D.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particlesGazi, I. F.; Tsimihodimos, V.; Tselepis, A. D.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A(2)Saougos, V. G.; Tambaki, A. P.; Kalogirou, M.; Kostapanos, M.; Gazi, I. F.; Wolfert, R. L.; Elisaf, M.; Tselepis, A. D.24-Nov-2015
Effect of Ezetimibe on Markers of Oxidative Stress in Patients with HypercholesterolemiaKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015
The effect of orlistat and fenofibrate, alone or in combination, on small dense LDL and lipoprotein-associated phospholipase A2 in obese patients with metabolic syndromeFilippatos, T. D.; Gazi, I. F.; Liberopoulos, E. N.; Athyros, V. G.; Elisaf, M. S.; Tselepis, A. D.; Kiortsis, D. N.24-Nov-2015
The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndromeFilippatos, T. D.; Liberopoulos, E. N.; Kostapanos, M.; Gazi, I. F.; Papavasiliou, E. C.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015
Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomicsPsihogios, N. G.; Gazi, I. F.; Elisaf, M. S.; Seferiadis, K. I.; Bairaktari, E. T.24-Nov-2015
High-Density Lipoprotein Subclasses in Patients with or without the Metabolic SyndromeLagos, K. G.; Gazi, I. F.; Kostapanos, M. S.; Filippatos, T.; Kazakou, P. S.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015
Hypertriglyceridaemic waist phenotype definitions and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Kostapanos, M. S.; Saougos, V. G.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterolGazi, I. F.; Filippatos, T. D.; Tsimihodimos, V.; Saougos, V. G.; Liberopoulos, E. N.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Increased plasma visfatin concentration is a marker of an atherogenic metabolic profileFilippatos, T. D.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Mikhailidis, D. P.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
Increased plasma visfatin levels in subjects with the metabolic syndromeFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Lagos, K.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015
LDL-cholesterol calculation formulas in patients with or without the metabolic syndromeGazi, I. F.; Elisaf, M. S.24-Nov-2015
Leptospirosis is Associated with Markedly Increased Triglycerides and Small Dense Low-Density Lipoprotein and Decreased High-Density LipoproteinGazi, I. F.; Apostolou, F.; Liberopoulos, E. N.; Filippatos, T. D.; Tellis, C. C.; Elisaf, M. S.; Tselepis, A. D.24-Nov-2015
Orlistat-associated adverse effects and drug interactions: a critical reviewFilippatos, T. D.; Derdemezis, C. S.; Gazi, I. F.; Nakou, E. S.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015
Persistence of an atherogenic lipid profile after treatment of acute infection with brucellaApostolou, F.; Gazi, I. F.; Kostoula, A.; Tellis, C. C.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015
Plasma Visfatin Concentration Is a Marker of an Atherogenic Metabolic ProfileFilippatos, T.; Tsimihodimos, V.; Derdemezis, C. S.; Gazi, I. F.; Saougos, V.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015